Celularity face Nasdaq listing rule breach after missing Q1 10-Q SEC filing
· seekingalpha.com
Celularity (CELU) gets Nasdaq notice for late Q1 2026 10-Q filing; learn deadlines, extension options, and what it means for investors—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...